Blueprint (Bryan Johnson)

Thesis

Blueprint is Bryan Johnson's personal longevity protocol turned consumer brand. The company raised $60M from celebrity angels including Kim Kardashian, Naval Ravikant, Alex Hormozi, and the Winklevoss twins. Johnson's extreme personal anti-aging protocol has generated massive media attention, making Blueprint one of the most recognizable longevity brands globally. The bull case is that Johnson is building the 'Apple of longevity'. A premium brand that could command extraordinary margins in the $4.2T wellness market. The celebrity investor roster provides distribution and cultural relevance that pure biotech companies lack. However, there is no token, no public stock, and no crowdfunding campaign. Making Blueprint uninvestable for most people. More critically, Johnson's personal Epstein correspondence revelations (February 2026) add significant reputational risk. The brand is inseparable from Johnson's personal image, which creates key-man risk that few consumer brands face. This is a watch-list entry rather than an actionable investment. If Blueprint eventually IPOs or offers equity crowdfunding, the reputational risk premium would need to be carefully assessed against the brand's cultural momentum.

Catalysts

• +$60M raised from celebrity angels (Kardashian, Naval, Hormozi, Winklevoss)
• +One of the most recognizable longevity brands globally via media attention
• +Premium positioning in $4.2T wellness market

Risks

• -No token, no public stock, no crowdfunding. Currently uninvestable
• -Bryan Johnson Epstein correspondence revelations (Feb 2026) create reputational risk
• -Brand inseparable from Johnson's personal image. Extreme key-man risk

Common questions